TY  - JOUR
T1  - Management of Primary Non-Aggressive Mandibular Giant Cell Tumor: A 14 Years’ Experience
AU - , Paolo Difalco AU - Tortorici, Silvia AU - , Maria Lidia Buzzanca AU - , Francesco Burruano AU - , Luigi Caradonna 
JO  - Research Journal of Biological Sciences
VL  - 6
IS  - 8
SP  - 386
EP  - 388
PY  - 2011
DA  - 2001/08/19
SN  - 1815-8846
DO  - rjbsci.2011.386.388
UR  - https://makhillpublications.co/view-article.php?doi=rjbsci.2011.386.388
KW  - Bony lesion
KW  -marginal osteotomy
KW  -bony healing
KW  -jaws
KW  -management
KW  -Italy
AB  - Giant cell tumor is a rare non-odontogenic lesion that represents approximately 4-5% of all primary bone tumors. Such lesions derive their actual name from the constant presence of numerous giant cells, similar to osteoclasts. All the giant cell tumors hystorically is treated with curettage. Because this conservative approach is often associated with a recurrence rate of up to 70%, aggressive resection has become the standard practice. Unfortunately, recurrence after wide resection is about 7%. The aim of the study is to describe the 14 years single institution experience with management of primary non-aggressive giant cell tumor of the jaws bone.
ER  -